{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T07:41:54Z","timestamp":1791013314604,"version":"4.1.0"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"14","license":[{"start":{"date-parts":[[2007,4,26]],"date-time":"2007-04-26T00:00:00Z","timestamp":1177545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2007,4,26]],"date-time":"2007-04-26T00:00:00Z","timestamp":1177545600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Gene Ther"],"published-print":{"date-parts":[[2007,7]]},"DOI":"10.1038\/sj.gt.3302961","type":"journal-article","created":{"date-parts":[[2007,4,26]],"date-time":"2007-04-26T09:11:08Z","timestamp":1177578668000},"page":"1065-1077","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":82,"title":["Significantly increased lifespan and improved behavioral performances by rAAV gene delivery in adult mucopolysaccharidosis IIIB mice"],"prefix":"10.1038","volume":"14","author":[{"given":"H","family":"Fu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J S","family":"Jennings","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S S","family":"Moy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Perez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"DiRosario","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D M","family":"McCarty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Muenzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2007,4,26]]},"reference":[{"key":"BF3302961_CR1","first-page":"3421","volume-title":"The Metabolic & Molecular Basis of Inherited Disease","author":"EF Neufeld","year":"2001","unstructured":"Neufeld EF, Muenzer J . The mucopolysaccharidoses. In: Scriver CR, Beaudet AL, Sly WS, Valle D (eds). The Metabolic & Molecular Basis of Inherited Disease. McGraw-Hill: New York, St Louis, San Francisco, 2001, pp 3421\u20133452."},{"key":"BF3302961_CR2","doi-asserted-by":"publisher","first-page":"14505","DOI":"10.1073\/pnas.96.25.14505","volume":"96","author":"HH Li","year":"1999","unstructured":"Li HH, Yu WH, Rozengurt N, Zhao HZ, Lyons KM, Anagnostaras S et al. Mouse model of Sanfilippo syndrome type B produced by targeted disruption of the gene encoding alpha-N-acetylglucosaminidase. Proc Natl Acad Sci USA 1999; 96: 14505\u201314510.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF3302961_CR3","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1002\/cne.20355","volume":"480","author":"R McGlynn","year":"2004","unstructured":"McGlynn R, Dobrenis K, Walkley SU . Differential subcellular localization of cholesterol, gangliosides, and glycosaminoglycans in murine models of mucopolysaccharide storage disorders. J Comp Neurol 2004; 480: 415\u2013426.","journal-title":"J Comp Neurol"},{"key":"BF3302961_CR4","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1136\/adc.76.2.92","volume":"76","author":"A Vellodi","year":"1997","unstructured":"Vellodi A, Young EP, Cooper A, Wraith JE, Winchester B, Meaney C et al. Bone marrow transplantation for mucopolysaccharidosis type I: experience of two British centres. Arch Dis Child 1997; 76: 92\u201399.","journal-title":"Arch Dis Child"},{"key":"BF3302961_CR5","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1038\/sj.bmt.1705401","volume":"38","author":"J Cox-Brinkman","year":"2006","unstructured":"Cox-Brinkman J, Boelens JJ, Wraith JE, O'Meara A, Veys P, Wijburg FA et al. Haematopoietic cell transplantation (HCT) in combination with enzyme replacement therapy (ERT) in patients with Hurler syndrome. Bone Marrow Transplant 2006; 38: 17\u201321.","journal-title":"Bone Marrow Transplant"},{"key":"BF3302961_CR6","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1517\/13543784.11.5.675","volume":"11","author":"ED Kakkis","year":"2002","unstructured":"Kakkis ED . Enzyme replacement therapy for the mucopolysaccharide storage disorders. Expert Opin Investig Drugs 2002; 11: 675\u2013685.","journal-title":"Expert Opin Investig Drugs"},{"key":"BF3302961_CR7","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1111\/j.1651-2227.2002.tb03118.x","volume":"91","author":"J Muenzer","year":"2002","unstructured":"Muenzer J, Lamsa JC, Garcia A, Dacosta J, Garcia J, Treco DA . Enzyme replacement therapy in mucopolysaccharidosis type II (Hunter syndrome): a preliminary report. Acta Paediatr Suppl 2002; 91: 98\u201399.","journal-title":"Acta Paediatr Suppl"},{"key":"BF3302961_CR8","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1038\/sj.ejhg.5200242","volume":"7","author":"B Weber","year":"1999","unstructured":"Weber B, Guo XH, Kleijer WJ, van de Kamp JJ, Poorthuis BJ, Hopwood JJ . Sanfilippo type B syndrome (mucopolysaccharidosis III B): allelic heterogeneity corresponds to the wide spectrum of clinical phenotypes. Eur J Hum Genet 1999; 7: 34\u201344.","journal-title":"Eur J Hum Genet"},{"key":"BF3302961_CR9","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1126\/science.162.3853.570","volume":"162","author":"JC Fratantoni","year":"1968","unstructured":"Fratantoni JC, Hall CW, Neufeld EF . Hurler and Hunter syndromes: mutual correction of the defect in cultured fibroblasts. Science 1968; 162: 570\u2013572.","journal-title":"Science"},{"key":"BF3302961_CR10","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1007\/BF00219337","volume":"88","author":"P Leinekugel","year":"1992","unstructured":"Leinekugel P, Michel S, Conzelmann E, Sandhoff K . Quantitative correlation between the residual activity of beta-hexosaminidase A and arylsulfatase A and the severity of the resulting lysosomal storage disease. Hum Genet 1992; 88: 513\u2013523.","journal-title":"Hum Genet"},{"key":"BF3302961_CR11","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1159\/000203880","volume":"95","author":"JL Abkowitz","year":"1996","unstructured":"Abkowitz JL, Persik MT, Catlin SN, Guttorp P . Simulation of hematopoiesis: implications for the gene therapy of lysosomal enzyme disorders. Acta Haematol 1996; 95: 213\u2013217.","journal-title":"Acta Haematol"},{"key":"BF3302961_CR12","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1002\/bies.950170310","volume":"17","author":"KI Berns","year":"1995","unstructured":"Berns KI, Linden RM . The cryptic life style of adeno-associated virus. Bioessays 1995; 17: 237\u2013245.","journal-title":"Bioessays"},{"key":"BF3302961_CR13","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1016\/j.ymthe.2003.08.021","volume":"8","author":"H Fu","year":"2003","unstructured":"Fu H, Muenzer J, Samulski RJ, Breese G, Sifford J, Zeng X et al. Self-complementary adeno-associated virus serotype 2 vector: global distribution and broad dispersion of AAV-mediated transgene expression in mouse brain. Mol Ther 2003; 8: 911\u2013917.","journal-title":"Mol Ther"},{"key":"BF3302961_CR14","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1038\/ng1094-148","volume":"8","author":"MG Kaplitt","year":"1994","unstructured":"Kaplitt MG, Leone P, Samulski RJ, Xiao X, Pfaff DW, O'Malley KL et al. Long-term gene expression and phenotypic correction using adeno-associated virus vectors in the mammalian brain. Nat Genet 1994; 8: 148\u2013154.","journal-title":"Nat Genet"},{"key":"BF3302961_CR15","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1038\/sj.gt.3300931","volume":"6","author":"SS Elliger","year":"1999","unstructured":"Elliger SS, Elliger CA, Aguilar CP, Raju NR, Watson GL . Elimination of lysosomal storage in brains of MPS VII mice treated by intrathecal administration of an adeno-associated virus vector. Gene Therapy 1999; 6: 1175\u20131178.","journal-title":"Gene Therapy"},{"key":"BF3302961_CR16","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1006\/mthe.1999.0005","volume":"1","author":"A Bosch","year":"2000","unstructured":"Bosch A, Perret E, Desmaris N, Heard JM . Long-term and significant correction of brain lesions in adult mucopolysaccharidosis type VII mice using recombinant AAV vectors. Mol Ther 2000; 1: 63\u201370.","journal-title":"Mol Ther"},{"key":"BF3302961_CR17","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1006\/mthe.2001.0514","volume":"5","author":"HF Fu","year":"2002","unstructured":"Fu HF, Samulski RJF, McCown TJF, Picornell YJF, Fletcher DF, Muenzer J . Neurological correction of lysosomal storage in a mucopolysaccharidosis IIIB mouse model by adeno-associated virus-mediated gene delivery. Mol Ther 2002; 5: 42\u201349.","journal-title":"Mol Ther"},{"key":"BF3302961_CR18","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1002\/ana.10373","volume":"52","author":"GG Heuer","year":"2002","unstructured":"Heuer GG, Passini MA, Jiang K, Parente MK, Lee VM, Trojanowski JQ et al. Selective neurodegeneration in murine mucopolysaccharidosis VII is progressive and reversible. Ann Neurol 2002; 52: 762\u2013770.","journal-title":"Ann Neurol"},{"key":"BF3302961_CR19","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1002\/ana.20150","volume":"56","author":"N Desmaris","year":"2004","unstructured":"Desmaris N, Verot L, Puech JP, Caillaud C, Vanier MT, Heard JM . Prevention of neuropathology in the mouse model of Hurler syndrome. Ann Neurol 2004; 56: 68\u201376.","journal-title":"Ann Neurol"},{"key":"BF3302961_CR20","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/S0896-6273(02)01054-1","volume":"36","author":"WM Pardridge","year":"2002","unstructured":"Pardridge WM . Drug and gene delivery to the brain: the vascular route. Neuron 2002; 36: 555\u2013558.","journal-title":"Neuron"},{"key":"BF3302961_CR21","doi-asserted-by":"publisher","first-page":"5760","DOI":"10.1073\/pnas.102175599","volume":"99","author":"WS Sly","year":"2002","unstructured":"Sly WS, Vogler C . Brain-directed gene therapy for lysosomal storage disease: going well beyond the blood\u2013brain barrier. Proc Natl Acad Sci USA 2002; 99: 5760\u20135762.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF3302961_CR22","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1006\/mthe.2001.0520","volume":"5","author":"BK Kaspar","year":"2002","unstructured":"Kaspar BK, Erickson D, Schaffer D, Hinh L, Gage FH, Peterson DA . Targeted retrograde gene delivery for neuronal protection. Mol Ther 2002; 5: 50\u201356.","journal-title":"Mol Ther"},{"key":"BF3302961_CR23","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1016\/j.ymthe.2005.01.011","volume":"11","author":"MA Passini","year":"2005","unstructured":"Passini MA, Macauley SL, Huff MR, Taksir TV, Bu J, Wu IH et al. AAV vector-mediated correction of brain pathology in a mouse model of Niemann-Pick A disease. Mol Ther 2005; 11: 754\u2013762.","journal-title":"Mol Ther"},{"key":"BF3302961_CR24","doi-asserted-by":"publisher","first-page":"10229","DOI":"10.1523\/JNEUROSCI.3558-04.2004","volume":"24","author":"A Cressant","year":"2004","unstructured":"Cressant A, Desmaris N, Verot L, Brejot T, Froissart R, Vanier MT et al. Improved behavior and neuropathology in the mouse model of Sanfilippo type IIIB disease after adeno-associated virus-mediated gene transfer in the striatum. J Neurosci 2004; 24: 10229\u201310239.","journal-title":"J Neurosci"},{"key":"BF3302961_CR25","first-page":"328","volume":"49","author":"MS Sands","year":"1999","unstructured":"Sands MS, Barker JE . Percutaneous intravenous injection in neonatal mice. Lab Anim Sci 1999; 49: 328\u2013330.","journal-title":"Lab Anim Sci"},{"key":"BF3302961_CR26","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1016\/j.ymthe.2004.03.011","volume":"9","author":"SD Hartung","year":"2004","unstructured":"Hartung SD, Frandsen JL, Pan D, Koniar BL, Graupman P, Gunther R et al. Correction of metabolic, craniofacial, and neurologic abnormalities in MPS I mice treated at birth with adeno-associated virus vector transducing the human alpha-L-iduronidase gene. Mol Ther 2004; 9: 866\u2013875.","journal-title":"Mol Ther"},{"key":"BF3302961_CR27","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1016\/j.ymthe.2004.10.006","volume":"11","author":"H Kobayashi","year":"2005","unstructured":"Kobayashi H, Carbonaro D, Pepper K, Petersen D, Ge S, Jackson H et al. Neonatal gene therapy of MPS I mice by intravenous injection of a lentiviral vector. Mol Ther 2005; 11: 776\u2013789.","journal-title":"Mol Ther"},{"key":"BF3302961_CR28","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.ymgme.2004.01.015","volume":"82","author":"RL Mango","year":"2004","unstructured":"Mango RL, Xu L, Sands MS, Vogler C, Seiler G, Schwarz T et al. Neonatal retroviral vector-mediated hepatic gene therapy reduces bone, joint, and cartilage disease in mucopolysaccharidosis VII mice and dogs. Mol Genet Metab 2004; 82: 4\u201319.","journal-title":"Mol Genet Metab"},{"key":"BF3302961_CR29","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1023\/A:1007049806660","volume":"20","author":"SI Rapoport","year":"2000","unstructured":"Rapoport SI . Osmotic opening of the blood\u2013brain barrier: principles, mechanism, and therapeutic applications. Cell Mol Neurobiol 2000; 20: 217\u2013230.","journal-title":"Cell Mol Neurobiol"},{"key":"BF3302961_CR30","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1007\/s11060-005-9038-4","volume":"77","author":"WA Hall","year":"2006","unstructured":"Hall WA, Doolittle ND, Daman M, Bruns PK, Muldoon L, Fortin D et al. Osmotic blood\u2013brain barrier disruption chemotherapy for diffuse pontine gliomas. J Neurooncol 2006; 77: 279\u2013284.","journal-title":"J Neurooncol"},{"key":"BF3302961_CR31","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.1200\/JCO.1991.9.9.1580","volume":"9","author":"EAF Neuwelt","year":"1991","unstructured":"Neuwelt EAF, Goldman DLF, Dahlborg SAF, Crossen JF, Ramsey FF, Roman-Goldstein SF et al. Primary CNS lymphoma treated with osmotic blood-brain barrier disruption: prolonged survival and preservation of cognitive function. J Clin Oncol 1991; 9: 1580\u20131590.","journal-title":"J Clin Oncol"},{"key":"BF3302961_CR32","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1097\/00004424-199112000-00012","volume":"26","author":"AJF Wilson","year":"1991","unstructured":"Wilson AJF, Evill CAF, Sage MR . Effects of nonionic contrast media on the blood\u2013brain barrier. Osmolality versus chemotoxicity. Invest Radiol 1991; 26: 1091\u20131094.","journal-title":"Invest Radiol"},{"key":"BF3302961_CR33","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1038\/sj.gt.3301420","volume":"8","author":"TM Daly","year":"2001","unstructured":"Daly TM, Ohlemiller KK, Roberts MS, Vogler CA, Sands MS . Prevention of systemic clinical disease in MPS VII mice following AAV-mediated neonatal gene transfer. Gene Therapy 2001; 8: 1291\u20131298.","journal-title":"Gene Therapy"},{"key":"BF3302961_CR34","doi-asserted-by":"publisher","first-page":"2296","DOI":"10.1073\/pnas.96.5.2296","volume":"96","author":"TM Daly","year":"1999","unstructured":"Daly TM, Vogler C, Levy B, Haskins ME, Sands MS . Neonatal gene transfer leads to widespread correction of pathology in a murine model of lysosomal storage disease. Proc Natl Acad Sci USA 1999; 96: 2296\u20132300.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF3302961_CR35","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.ymthe.2006.02.012","volume":"14","author":"BA Karolewski","year":"2006","unstructured":"Karolewski BA, Wolfe JH . Genetic correction of the fetal brain increases the lifespan of mice with the severe multisystemic disease mucopolysaccharidosis type VII. Mol Ther 2006; 14: 14\u201324.","journal-title":"Mol Ther"},{"key":"BF3302961_CR36","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1016\/j.ymthe.2005.04.019","volume":"12","author":"D Lin","year":"2005","unstructured":"Lin D, Fantz CR, Levy B, Rafi MA, Vogler C, Wenger DA et al. AAV2\/5 vector expressing galactocerebrosidase ameliorates CNS disease in the murine model of globoid-cell leukodystrophy more efficiently than AAV2. Mol Ther 2005; 12: 422\u2013430.","journal-title":"Mol Ther"},{"key":"BF3302961_CR37","doi-asserted-by":"publisher","first-page":"10373","DOI":"10.1073\/pnas.0603765103","volume":"103","author":"MB Cachon-Gonzalez","year":"2006","unstructured":"Cachon-Gonzalez MB, Wang SZ, Lynch A, Ziegler R, Cheng SH, Cox TM . Effective gene therapy in an authentic model of Tay-Sachs-related diseases. Proc Natl Acad Sci USA 2006; 103: 10373\u201310378.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF3302961_CR38","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1056\/NEJM200101183440304","volume":"344","author":"ED Kakkis","year":"2001","unstructured":"Kakkis ED, Muenzer J, Tiller GE, Waber L, Belmont J, Passage M et al. Enzyme-replacement therapy in mucopolysaccharidosis I. N Engl J Med 2001; 344: 182\u2013188.","journal-title":"N Engl J Med"},{"key":"BF3302961_CR39","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.ymgme.2006.05.005","volume":"89","author":"AC Crawley","year":"2006","unstructured":"Crawley AC, King B, Berg T, Meikle PJ, Hopwood JJ . Enzyme replacement therapy in alpha-mannosidosis guinea-pigs. Mol Genet Metab 2006; 89: 48\u201357.","journal-title":"Mol Genet Metab"},{"key":"BF3302961_CR40","doi-asserted-by":"publisher","first-page":"e681","DOI":"10.1542\/peds.2004-1023","volume":"115","author":"P Harmatz","year":"2005","unstructured":"Harmatz P, Ketteridge D, Giugliani R, Guffon N, Teles EL, Miranda MC et al. Direct comparison of measures of endurance, mobility, and joint function during enzyme-replacement therapy of mucopolysaccharidosis VI (Maroteaux\u2013Lamy syndrome): results after 48 weeks in a phase 2 open-label clinical study of recombinant human N-acetylgalactosamine 4-sulfatase. Pediatrics 2005; 115: e681\u2013e689.","journal-title":"Pediatrics"},{"key":"BF3302961_CR41","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1006\/prep.2000.1230","volume":"19","author":"KW Zhao","year":"2000","unstructured":"Zhao KW, Neufeld EF . Purification and characterization of recombinant human alpha-N-acetylglucosaminidase secreted by Chinese hamster ovary cells. Protein Expr Purif 2000; 19: 202\u2013211.","journal-title":"Protein Expr Purif"},{"key":"BF3302961_CR42","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1006\/prep.2000.1361","volume":"21","author":"B Weber","year":"2001","unstructured":"Weber B, Hopwood JJ, Yogalingam G . Expression and characterization of human recombinant and alpha-N-acetylglucosaminidase. Protein Expr Purif 2001; 21: 251\u2013259.","journal-title":"Protein Expr Purif"},{"key":"BF3302961_CR43","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1111\/j.1600-0854.2006.00429.x","volume":"7","author":"X Ni","year":"2006","unstructured":"Ni X, Morales CR . The lysosomal trafficking of acid sphingomyelinase is mediated by sortilin and mannose 6-phosphate receptor. Traffic 2006; 7: 889\u2013902.","journal-title":"Traffic"},{"key":"BF3302961_CR44","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1203\/01.PDR.0000129661.40499.12","volume":"56","author":"BL Gliddon","year":"2004","unstructured":"Gliddon BL, Hopwood JJ . Enzyme-replacement therapy from birth delays the development of behavior and learning problems in mucopolysaccharidosis type IIIA mice. Pediatr Res 2004; 56: 65\u201372.","journal-title":"Pediatr Res"},{"key":"BF3302961_CR45","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1016\/j.jpeds.2004.03.018","volume":"144","author":"P Harmatz","year":"2004","unstructured":"Harmatz P, Whitley CB, Waber L, Pais R, Steiner R, Plecko B et al. Enzyme replacement therapy in mucopolysaccharidosis VI (Maroteaux\u2013Lamy syndrome). J Pediatr 2004; 144: 574\u2013580.","journal-title":"J Pediatr"},{"key":"BF3302961_CR46","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1203\/00006450-199606000-00019","volume":"39","author":"C Vogler","year":"1996","unstructured":"Vogler C, Sands MS, Levy B, Galvin N, Birkenmeier EH, Sly WS . Enzyme replacement with recombinant beta-glucuronidase in murine mucopolysaccharidosis type VII: impact of therapy during the first six weeks of life on subsequent lysosomal storage, growth, and survival. Pediatr Res 1996; 39: 1050\u20131054.","journal-title":"Pediatr Res"},{"key":"BF3302961_CR47","doi-asserted-by":"publisher","first-page":"6101","DOI":"10.1073\/pnas.93.12.6101","volume":"93","author":"HG Zhao","year":"1996","unstructured":"Zhao HG, Li HH, Bach G, Schmidtchen A, Neufeld EF . The molecular basis of Sanfilippo syndrome type B. Proc Natl Acad Sci USA 1996; 93: 6101\u20136105.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF3302961_CR48","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1038\/sj.gt.3300938","volume":"6","author":"S Zolotukhin","year":"1999","unstructured":"Zolotukhin S, Byrne BJ, Mason E, Zolotukhin I, Potter M, Chesnut K et al. Recombinant adeno-associated virus purification using novel methods improves infectious titer and yield. Gene Therapy 1999; 6: 973\u2013985.","journal-title":"Gene Therapy"},{"key":"BF3302961_CR49","first-page":"567","volume-title":"Techniques in Diagnostic Human Biochemical Genetics \u2013 A Laboratory Manual","author":"JN Thompson","year":"1991","unstructured":"Thompson JN, Nowakoski RW . Enzymatic diagnosis of selected mucopolysaccharidoses: Hunter, Morquio type A, and Sanfilippo types A, B, C, and D, and procedures for measurement of 35SO4-glycosaminoglycans. In: Hommes FA (ed). Techniques in Diagnostic Human Biochemical Genetics \u2013 A Laboratory Manual. Wiley-Liss: New York, 1991, pp 567\u2013586."},{"key":"BF3302961_CR50","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1006\/abio.1994.1425","volume":"221","author":"CH van de Lest","year":"1994","unstructured":"van de Lest CH, Versteeg EM, Veerkamp JH, van Kuppevelt TH . Quantification and characterization of glycosaminoglycans at the nanogram level by a combined azure A-silver staining in agarose gels. Anal Biochem 1994; 221: 356\u2013361.","journal-title":"Anal Biochem"},{"key":"BF3302961_CR51","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1093\/clinchem\/35.7.1472","volume":"35","author":"JG de Jong","year":"1989","unstructured":"de Jong JG, Wevers RA, Laarakkers C, Poorthuis BJ . Dimethylmethylene blue-based spectrophotometry of glycosaminoglycans in untreated urine: a rapid screening procedure for mucopolysaccharidoses. Clin Chem 1989; 35: 1472\u20131477.","journal-title":"Clin Chem"},{"key":"BF3302961_CR52","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1016\/S0092-8674(00)80354-2","volume":"90","author":"N Lijam","year":"1997","unstructured":"Lijam N, Paylor R, McDonald MP, Crawley JN, Deng CX, Herrup K et al. Social interaction and sensorimotor gating abnormalities in mice lacking Dvl1. Cell 1997; 90: 895\u2013905.","journal-title":"Cell"},{"key":"BF3302961_CR53","doi-asserted-by":"publisher","first-page":"7323","DOI":"10.1523\/JNEUROSCI.21-18-07323.2001","volume":"21","author":"EC Warburton","year":"2001","unstructured":"Warburton EC, Baird A, Morgan A, Muir JL, Aggleton JP . The conjoint importance of the hippocampus and anterior thalamic nuclei for allocentric spatial learning: evidence from a disconnection study in the rat. J Neurosci 2001; 21: 7323\u20137330.","journal-title":"J Neurosci"}],"container-title":["Gene Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/3302961.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/3302961","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/3302961.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,30]],"date-time":"2022-03-30T04:41:17Z","timestamp":1648615277000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/3302961"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,4,26]]},"references-count":53,"journal-issue":{"issue":"14","published-print":{"date-parts":[[2007,7]]}},"alternative-id":["BF3302961"],"URL":"https:\/\/doi.org\/10.1038\/sj.gt.3302961","relation":{},"ISSN":["0969-7128","1476-5462"],"issn-type":[{"value":"0969-7128","type":"print"},{"value":"1476-5462","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,4,26]]},"assertion":[{"value":"18 August 2006","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 February 2007","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 February 2007","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 April 2007","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}